Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03923556 · ClinicalTrials.gov registry record · Phase 4
Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery
A Phase 4 study of Kidney Transplant; Complications and Postoperative Residual Curarization, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 4
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT03923556: Completed Phase 4 study of Kidney Transplant; Complications and Postoperative Residual Curarization, sponsored by University of Colorado, Denver.
NCT03923556 is a Phase 4 study of Kidney Transplant; Complications and Postoperative Residual Curarization that has completed, run by University of Colorado, Denver. The registered enrollment target is 84 participants, below the 117-participant average among 19 other Kidney Transplant; Complications trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03923556, a Phase 4 study of Kidney Transplant; Complications and Postoperative Residual Curarization, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare two medications that reverse muscle paralysis at the end of kidney transplant surgery with the goal of reducing residual muscle weakness and insufficient respiratory function after surgery.
Primary Outcome
Presence of one or more episodes of hypoventilation in PACU, adjusted to qTOF and other confounders
Conditions Studied
Interventions
- DRUG Sugammadex
- DRUG Neostigmine
Study Locations (1)
Colorado
- University of Colorado Hospital - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2021-02-02 |
| Est. Completion | 2023-10-30 |
| Phase | Phase 4 |
What the finished NCT03923556 record still lists
NCT03923556 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 117-participant average among 19 other Kidney Transplant; Complications trials with a reported enrollment target (28% lower).
The record links to 3 conditions, with Kidney Transplant; Complications appearing as the primary indexed condition, and to 2 interventions - of which Sugammadex is the first listed.
NCT03923556 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT03923556 about?
NCT03923556 is a clinical study titled "Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery". The purpose of this study is to compare two medications that reverse muscle paralysis at the end of kidney transplant surgery with the goal of reducing residual muscle weakness and insufficient respiratory function after surgery.
What is the current status of trial NCT03923556?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 84 participants. The study started on 2021-02-02. Estimated completion is 2023-10-30.
What conditions does trial NCT03923556 study?
This clinical trial studies the following conditions: Kidney Transplant; Complications, Postoperative Residual Curarization, Postoperative Residual Weakness.
What interventions are being tested in trial NCT03923556?
The interventions under investigation include: Sugammadex (DRUG), Neostigmine (DRUG).
Who is sponsoring clinical trial NCT03923556?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03923556 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Transplant; Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03923556's enrollment target sits among peer trials
84 9th of 19 higher than 11 of 19 other Kidney Transplant; Complications trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Transplant; Complications trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients
RECRUITING · Phase 4
-
Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
RECRUITING · Phase 4
-
Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients
RECRUITING · Phase 4
-
Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants
ACTIVE NOT RECRUITING · Phase 4
-
A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients
ACTIVE NOT RECRUITING · Phase 4
-
Immune Registry for BK in Kidney Transplant Recipients
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI